Download Files:
Products Details
Product Description
– Revusiran sodium is a 1st-generation short interfering RNA, which directed against transthyretin (TTR) mRNA. Revusiran sodium can be used for transthyretin (TTR)-mediated amyloidosis research[1].
Web ID
– HY-132590A
Shipping
– Room temperature
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– N/A
References
– [1]Jessica E Sutherland, et al. Nonclinical Safety Profile of Revusiran, a 1st-Generation GalNAc-siRNA Conjugate for Treatment of Hereditary Transthyretin-Mediated Amyloidosis. Nucleic Acid Ther. 2020 Feb;30(1):33-49.
Molecular Weight
– N/A
SMILES
– [Revusiran (sodium)]
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in H2O
Target
– Small Interfering RNA (siRNA);Transthyretin (TTR)
Pathway
– Epigenetics;Neuronal Signaling
Product type
– Oligonucleotides
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
